Given that NAA10 alterations directly contribute to human developmental disorders and cancers, it is critical to develop NAA10 inhibitors or other molecular tools to further investigate its functional roles and underlying mechanisms in these diseases, and to evaluate its potential as a therapeutic target. This evidence concerns the gene NAA10 and cancer.